Skip to main content

J&J Talc Lawsuit: U.S District Judge Rejects Transfer

J&J Talc Lawsuit: U.S District Judge Rejects Transfer

J&J Talc Lawsuit: U.S District Judge Rejects Transfer

Introduction

U.S. District Judge Mark Kearney of the Eastern District of Pennsylvania on Tuesday dismissed Johnson & Johnson’s request to move a talcum powder cancer lawsuit out of Philadelphia, as he did not have jurisdiction over the claims. It is the first talc-related case to come before a Philadelphia jury.

A couple alleged J&J's talcum powder products for the wife's ovarian cancer in the Philadelphia County Court of Common Pleas in January 2017. The plaintiffs initially filed a claim against Imerys as well, but later dropped it in February. The plaintiffs are represented by Nancy Winkler and Todd Schoenhaus from Eisenberg, Rothweiler, Winkler, Eisenberg, & Jeck, as well as Ted Meadows of Beasley Allen.

Nearly 12,000 J&J Baby Powder lawsuits and Shower-to-Shower lawsuits are pending in courts nationwide, claiming that the manufacturer failed to warn about the risks of using talcum powder. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!